Search

This article is Part 3 of our three-part series summarizing how MSK’s biological insights and expertise fuel innovative treatment approaches for patients with rare head and neck cancers.

… Friday, March 22, 2024 This article is Part 3 of our three-part series summarizing how MSK’s biological insights and expertise fuel innovative treatment approaches for patients with rare head and neck cancers. In Part 3 below, we  summarize MSK-led advances in non-melanoma skin of the head and neck and

Many women are confused by conflicting guidelines on breast screening. And the latest recommendations made by the USPSTF are adding to that confusion. MSK experts are available to answer questions and explain what MSK recommends and why it is not altering its guidelines. To schedule an interview with a member of MSK’s breast cancer leadership team, please contact Nicole McNamara at [email protected].

… Monday, January 11, 2016 Many women are confused by conflicting guidelines on breast screening. And the latest recommendations made by the USPSTF are adding to that confusion. MSK experts are available to answer questions and explain what MSK recommends and why it is not altering its guidelines. To schedule

Women and ethnic minorities are underrepresented in science. Memorial Sloan Kettering is working to change that.

… Friday, November 2, 2018 Edwin Kamau (NYU) and Laura González-Fajardo (University of Connecticut) Graduate students Edwin Kamau (NYU) and Laura González-Fajardo (University of Connecticut) Patrick Cherubin (University of Central Florida) and Michael Riley II (University of Florida) Graduate students

Memorial Sloan Kettering Cancer Center (MSK) today announced the following awards and appointments.

… Thursday, June 6, 2024 Memorial Sloan Kettering Cancer Center (MSK) today announced the following awards and appointments: Andrea Cercek Named to the Inaugural 2024 TIME100 Health List Andrea Cercek Named to the Inaugural 2024 TIME100 Health List Andrea Cercek, MD , gastrointestinal oncologist, section

Memorial Sloan Kettering Cancer Center (MSK) has been recognized as the number one center for ear, nose, and throat care by U.S. News & World Report. MSK has been consistently ranked among the top two cancer centers in the country for over 30 years.

… Tuesday, July 27, 2021 Memorial Sloan Kettering Cancer Center (MSK) has been recognized as the number one center for ear, nose, and throat care by U.S. News & World Report in its annual Best Hospitals listing. MSK has been consistently ranked among the top two cancer centers in the country for over 30

Leptomeningeal metastasis, cancer that has spread to the areas surrounding the brain and spinal cord, has long been a formidable clinical challenge for oncologists. Researchers at Memorial Sloan Kettering Cancer Center have identified the molecular basis of this increasingly prevalent complication of cancer. With the help of a mouse model, researchers have identified a drug strategy that may combat this virtually untreatable condition. This research by Joan Massagué, PhD, Adrienne Boire, MD, PhD, and colleagues, was published in the March 9, 2017 issue of Cell. For more information on this work and to speak with the study authors, contact [email protected].

… Thursday, March 9, 2017 Bottom Line: Leptomeningeal metastasis, cancer that has spread to the areas surrounding the brain and spinal cord, has long been a formidable clinical challenge for oncologists. Researchers at Memorial Sloan Kettering Cancer Center (MSK) have identified the molecular basis of

In the future, more-advanced genetic testing might offer better ways to match up patients who need a bone marrow transplant with potential donors.

… Tuesday, September 4, 2012 Summary In the future, more-advanced genetic testing might offer better ways to match up patients who need a bone marrow transplant with potential donors. A recent study by Memorial Sloan Kettering researchers is a step in the direction of improving strategies to find matching

An international study led by MSK investigators has found that liquid biopsies may improve survival in people with lung cancer. These blood tests are easier for patients than more traditional tissue biopsies.

… Thursday, November 10, 2022 An international study led by MSK investigators has found that liquid biopsies may improve survival in people with lung cancer. These blood tests are easier for patients than more traditional tissue biopsies. Moments after getting bad news about her lung cancer , Joyce Tyson

In 2025, MSK was again ranked among the top organizations with the greatest number of highly cited scientific researchers worldwide, according to the annual list of Highly Cited Researchers, published by the Institute for Scientific Information at Clarivate.

… Wednesday, November 12, 2025 In science, having your research cited by other researchers is one of the most public signs of your influence — a mark that a study has become part of the foundation others are building upon. This year, Memorial Sloan Kettering Cancer Center (MSK) was again ranked among the

Meet the 11 new faculty members that have joined the Gerstner Sloan Kettering (GSK) Graduate School of Biomedical Sciences.

… Thursday, July 15, 2021 The Gerstner Sloan Kettering (GSK) Graduate School of Biomedical Sciences has welcomed 11 new faculty members since June 2020. These outstanding scientists, who are at the forefront of biomedical research, join a community of colleagues committed to fostering a robust and exciting